Cancer Council Queensland, Brisbane, Australia.
Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
J Adolesc Young Adult Oncol. 2020 Jun;9(3):402-409. doi: 10.1089/jayao.2019.0119. Epub 2019 Dec 12.
Breast cancer is the most common cancer diagnosed among adolescent and young adult (AYA) females worldwide, but epidemiological patterns unique to this group are often obscured when results are combined with older patients. This study investigates breast cancer incidence and survival among AYA females, including differences by broad stage at diagnosis. A retrospective, population-based cohort study was conducted using de-identified data for females in Queensland, Australia, aged 15-39 diagnosed with a first primary breast cancer between 1997 and 2014 with follow-up to December 31, 2016. Incidence rate trends were examined with Joinpoint analysis. Cause-specific survival was calculated for key characteristics, and 5-year adjusted hazard ratios (HRs) were estimated from a multivariable flexible parametric model. The study cohort comprised 2337 patients, of whom two-thirds ( = 1565, 67%) were diagnosed with advanced disease (tumor diameter >20 mm, lymph node involvement or presence of distant metastases at diagnosis). Incidence rates of localized tumors decreased by 1.9% per year (95% confidence interval [CI] -3.5% to -0.4%) over the study period, whereas the trend for advanced breast cancers remained stable. Five-year cause-specific survival increased from 85% to 92% for 2011-2014 compared to 1997-2001 (adjusted HR = 0.43, 95% CI = 0.29-0.65). Patients who were Indigenous from disadvantaged areas or diagnosed with advanced stage experienced significantly worse survival. The high proportion of younger females diagnosed with advanced breast cancer should be the focus of future campaigns to improve awareness and earlier detection. While survival has increased over time, further work is required to ensure that this progress is experienced equitably by all patients.
乳腺癌是全球青少年和年轻女性(AYA)中最常见的癌症,但当结果与老年患者合并时,该人群特有的流行病学模式往往被掩盖。本研究调查了 AYA 女性的乳腺癌发病率和生存率,包括不同广泛诊断阶段的差异。 本研究使用澳大利亚昆士兰州的匿名数据进行了回顾性、基于人群的队列研究,纳入了 1997 年至 2014 年间诊断为首次原发性乳腺癌的年龄在 15-39 岁的女性,随访至 2016 年 12 月 31 日。采用 Joinpoint 分析检查发病率趋势。对关键特征计算了特定原因的生存率,并从多变量灵活参数模型中估计了 5 年调整后的风险比(HR)。 该研究队列包括 2337 名患者,其中三分之二(n=1565,67%)被诊断为晚期疾病(肿瘤直径>20mm、诊断时淋巴结受累或存在远处转移)。在研究期间,局部肿瘤的发病率每年下降 1.9%(95%置信区间 [CI]:-3.5%至-0.4%),而晚期乳腺癌的趋势保持稳定。与 1997-2001 年相比,2011-2014 年 5 年特定原因生存率从 85%增加到 92%(调整后的 HR=0.43,95%CI=0.29-0.65)。来自贫困地区的土著患者或被诊断为晚期的患者的生存率明显较差。 应将年轻女性中诊断出患有晚期乳腺癌的比例较高作为未来提高认识和早期发现的重点。虽然生存率随着时间的推移有所提高,但仍需要进一步努力,以确保所有患者都能公平地受益于这一进展。